Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
life sciences
national blog main
new york blog main
new york top stories
adeno-associated virus
alexandria venture investments
alirocumab
alnylam pharmaceuticals
altitude life science ventures
american society of gene and cell therapy
amgen
arch venture partners
boston top stories
boxer capital
clinical trials
deals
dravet syndrome
drugs
ed kaye
encoded therapeutics
evercore isi
evolocumab
gene therapy
generation bio
heart attack
hemophilia
illumina
illumina ventures
inclisiran
joseph swartz
matrix capital management
medicines co.
menlo ventures
national top stories
new york
pcsk9 inhibitors
regeneron pharmaceuticals
regulatory elements
What
lasting
2
×
long
alnylam
based
cholesterol
crude
cutting
data
despite
drug
edge
effects
encoded
evidence
gene
heart
help
illumina’s
limited
limits
looms
lowering
medco
medicine
medicines
nabs
new
partner
pharmaceuticals
presented
progress
promising
push
reckoning
remains
rna
single
supporting
term
therapy
Language
Current search:
biotech
×
lasting
×
@xconomy.com
5 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms